Climacteric symptoms after oral and percutaneous hormone replacement therapy
Authors:
- J. JensenJJJ. Jensen
- B.J. RiisBRB.J. Riis
- P. RødbroPRP. Rødbro
- V. StrømVSV. Strøm
- C. ChristiansenCCC. Christiansen
- 1 November 1987
- Vol. 9 (3) , 207-215
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapyBJOG: An International Journal of Obstetrics & Gynaecology, 1986
- UNCOUPLING OF BONE FORMATION AND RESORPTION BY COMBINED OESTROGEN AND PROGESTAGEN THERAPY IN POSTMENOPAUSAL OSTEOPOROSISThe Lancet, 1985
- L‐norgestrel and progesterone have different influences on plasma lipoproteinsEuropean Journal of Clinical Investigation, 1983
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981
- A PROSPECTIVE, CONTROLLED TRIAL OF SIX FORMS OF HORMONE REPLACEMENT THERAPY GIVEN TO POSTMENOPAUSAL WOMENBJOG: An International Journal of Obstetrics & Gynaecology, 1979
- Conjugated equine oestrogens and blood clotting: a follow-up report.BMJ, 1977
- Selected Aspects of Endocrinology and Epidemiology of the Climacteric1977
- Estrogens and Endometrial Cancer in a Retirement CommunityNew England Journal of Medicine, 1976
- COMPARATIVE CLINICAL EVALUATION OF ESTROGENIC PREPARATIONS BY THE MENOPAUSAL AND AMENORRHEAL INDICES*†The Journal of Clinical Endocrinology & Metabolism, 1953